How is McMaster-Carr thinking about 3D printing with metal (not plastic)? The technology is still too expensive for much scale.
How is Helvetia dealing with potential regulatory concerns of the new and untested tech innovations?
How does Antidote make money, and do they bare any risk of making recruited patients aware of all the risks of signing up for a clinical trial?
What role do you think GMO cacao beans could play in the future, for example being more drought-resistant?
What opportunities are there for GMO alfalfa that is perhaps more water-efficient?
Would be great to hear more about how Aladdin plays into their overall strategy